2006
DOI: 10.1016/j.lfs.2006.01.034
|View full text |Cite
|
Sign up to set email alerts
|

Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
25
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(27 citation statements)
references
References 23 publications
2
25
0
Order By: Relevance
“…4 In double stained specimens, eNOS was stained as an intracytoplasmic brown color and thin granular structure with DAB chromogen (thin arrows) and apoptotic cell was stained as rough and reddish color with AEC chromogen (bold arrows). a Sildenafil group; b Vardenafil group Pediatr Surg Int (2008) 24:205-211 209 degraded by PDEs [20]. Thus inhibiting PDEs will elevate NO level in tissues and according to our findings this mechanism probably proceeds with the increasing of tissue NOS levels.…”
Section: Discussionsupporting
confidence: 59%
See 1 more Smart Citation
“…4 In double stained specimens, eNOS was stained as an intracytoplasmic brown color and thin granular structure with DAB chromogen (thin arrows) and apoptotic cell was stained as rough and reddish color with AEC chromogen (bold arrows). a Sildenafil group; b Vardenafil group Pediatr Surg Int (2008) 24:205-211 209 degraded by PDEs [20]. Thus inhibiting PDEs will elevate NO level in tissues and according to our findings this mechanism probably proceeds with the increasing of tissue NOS levels.…”
Section: Discussionsupporting
confidence: 59%
“…PDE5 inhibitors, work to improve ED by preventing the breakdown of cyclic GMP, the substance that promotes relaxation of smooth muscle cells in vascular system [18]. Although the main indication of these drugs is ED, the effectiveness of sildenafil in hypertensive cardiomyopathy [19], pulmonary hypertension [20], and renal damage via NO pathway [21] have been reported previously. Recently, FDA approved sildenafil in the treatment of pulmonary arterial hypertension of any functional class [22].…”
Section: Discussionmentioning
confidence: 99%
“…Although the main indication of PDE-5 inhibitors is ED, the effectiveness of sildenafil in hypertensive cardiomyopathy [15] , pulmonary hypertension [16] , and renal damage via the NO pathway [17] has been reported previously. The favorable effects of PDE-5 usage on several tissues and organs, such as in flap survival and trans- planted and other organs, have been recently reported [18][19][20] .…”
Section: Discussionmentioning
confidence: 88%
“…Another explanation would be related with the lower time spent to the PE-induced PH on other PE models (from 180 min to several hours) [27,28]. Anyway, if the activation of the inflammatory response with the release of vasoactive mediators and increase of oxidative stress play some role in the pathogenesis of PH associated with PE [21,29], levosimendan would also have the advantage of attenuating the PE-induced PH through mechanisms involving antioxidant effects [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…We have not measured any oxidative stress parameters like plasma nitrite/ nitrate concentrations and plasma lipid peroxide concentrations to demonstrate the presence of an increase in oxidative stress after lung embolization in PE group. Although we employed a relatively short period to embolize the lungs, a significant increase in plasma nitrite/nitrate concentrations were observed after 60 min of lung embolization in a canine PE model [29]. We were careful to analyze several PA rings from different lobs of both lungs of each animal to obtain a representative sample beyond the final distribution of blood clots.…”
Section: Limitationsmentioning
confidence: 99%